Homepage Slider
0 What impact could the microbiome have on CAR-T therapy? – an interview with M. Bilal Abid

Chimeric antigen receptor (CAR) T-cell therapy is a highly complex and innovative treatment that involves collecting and using the patients’ own immune cells to treat their cancers. In this interview we speak to M. Bilal Abid about what impact the gut microbiome could have on this immune-engaging therapy, and the regulations currently surrounding the use of probiotics.

1 2 3 10